Grantham, Mayo, Van Otterloo & Co (GMO)’s Varex Imaging VREX Stock Holding History
Bought
Maintained
Sold
Other funds holding VREX
Grantham, Mayo, Van Otterloo & Co (GMO)'s VREX Position: Q3 2026 in Review
Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Varex Imaging (VREX) in Q3 2026, closing a stake of 11,418 shares — an estimated $119K sold.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in VREX in Q3 2019 and held it in 11 quarters. The position peaked at $4.4M in Q3 2019. 180 funds tracked by Wall St. Rank hold VREX as of Q3 2026.
- Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Varex Imaging position as of Q3 2026 after selling out during the quarter.
- Grantham, Mayo, Van Otterloo & Co (GMO) sold 11,418 Varex Imaging shares in Q3 2026, an estimated $119K.
- Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Varex Imaging in Q3 2019 and held it in 11 quarters.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s Varex Imaging position peaked at $4.4M in Q3 2019.
- 180 funds tracked by Wall St. Rank held Varex Imaging as of Q3 2026.
Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q3 2026, filed 13 Nov 2026.